Patents Represented by Law Firm Vinson & Elkins
  • Patent number: 7964000
    Abstract: Biodiesel fuel blends with improved low temperature filterability include a biodiesel source with reduced glycerin contaminants, and reduced monopalmitin and monostearin contaminants, or with cold filter characteristics equivalent with the base diesel.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: June 21, 2011
    Assignee: Flint Hills Resources, L.P.
    Inventor: Charles Selvidge
  • Patent number: 7963089
    Abstract: The present disclosure is directed to processes for manufacturing shaped articles for unit-dose packaging with at least one formed recess (e.g., a blister), in particular for unit-dose packaging of pharmaceutical dosage forms. In certain embodiments, the first step of the process is directed to drawing the film material (e.g., metal-plastic foil) with one or more plungers to form a primary contour, the contour having a depth of at least 100% and up to 150% of the depth of the formed recess. The second stage involves shaping the primary contour with one or more plunger(s) to the desired formed recess, with a depth that is less than the depth of the primary contour, while substantially maintaining the surface area of the primary contour formed in the first stage. The formed recess may be formed using warm-forming or cold-forming techniques.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: June 21, 2011
    Assignee: Mystic Pharmaceuticals, Inc.
    Inventors: Jeffrey Nelson, Jon Olson
  • Patent number: 7966195
    Abstract: System and method for preparing patient order sets by an attending physician include optimization of orders particularly when multiple diagnoses are being treated.
    Type: Grant
    Filed: July 11, 2007
    Date of Patent: June 21, 2011
    Assignee: Intercede Health
    Inventors: Philip A. Sanger, Charles Robertson, Robert Weathersby
  • Patent number: 7892572
    Abstract: The invention provides a biocompatible material derived from keratin that is useful for many aspects of medical treatment of bone. The keratin material is preferably S-sulfonated and enriched in intermediate filament proteins of high molecular weight. The keratin material may be porous for use as a bone replacement and augmentation product but also provided is the use of dense keratin materials in bone treatment for use as an internal fixation appliance in the treatment of bone fractures and bone regeneration, and a method for preparing the keratin material for use in the preservation, restoration and development of form and function of bone.
    Type: Grant
    Filed: October 9, 2007
    Date of Patent: February 22, 2011
    Assignee: Keraplast Technologies, Ltd.
    Inventors: Philip Victor Peplow, Subasinghe Nisanke George Premalal Jayantha Dias, Alisa Dawn Roddick-Lanzilotta, Robert James Kelly
  • Patent number: 7887599
    Abstract: This invention is directed to the field of medical implants, and more specifically to biodegradable injectable implants and their methods of manufacture and use. The injectable implants disclosed herein comprise glycolic acid and bio-compatible/bio-absorbable polymeric particles containing a polymer of lactic acid. The particles are small enough to be injected through a needle but large enough to avoid engulfment by macrophages. The injectables of this invention may be in a pre-activated solid form or an activated form (e.g., injectable suspension or emulsion).
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: February 15, 2011
    Inventors: Crisoforo Peralta Casares, Daniel Leon de Lagarde
  • Patent number: 7831534
    Abstract: A method for providing a polyhierarchical classification includes identifying properties of objects useful for distinguishing objects under classification. A plurality of criteria are identified for specializing the identified properties. A form is chosen for attributive expressions that describe classification categories. The attributive expressions are customizable and encode compositions of object properties in terms of attributes from the plurality of criteria. A domain of applicability is identified for each criterion that is representable by attributive expressions, and a dependence relationship between criteria is defined by the inclusion of attributes in the attributive expressions, where a selected criterion depends on another criterion if its domain of applicability includes at least one attribute by the other criterion. A generating polyhierarchy of criteria is automatically established by the dependence relationships between the criteria.
    Type: Grant
    Filed: February 11, 2008
    Date of Patent: November 9, 2010
    Inventors: Pavel Babikov, Oleg Gontcharov, Maria Babikova
  • Patent number: 7824685
    Abstract: This invention relates to a gene encoding RTVP that has been shown to be up-regulated by p53 using differential display-PCR and subsequently by co-transfection studies. RTVP-1 mRNA is abundant in normal mouse and human prostatic epithelial cells and primary tumors, but is significantly down regulated in metastatic mouse and human prostate cancer. In prostate cancer cells overexpression of the mouse RTVP-1 gene (mRTVP-1) induced apoptosis that was accompanied by increased caspase 8, 9 and 3 activities. mRTVP-1-stimulated apoptosis was also associated with increased levels of bax, bad and activated BID; reduced levels of bcl-2 and bcl-XL; and cytosolic cytochrome c accumulation. Adenoviral-vector-mediated mRTVP-1 expression lead to potent growth suppression and antimetastatic activities in an orthotopic mouse model of prostate cancer in vivo. These therapeutic activities were associated with anti-angiogenic effects and importantly a local and systemic immune response.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: November 2, 2010
    Assignee: Baylor College of Medicine
    Inventors: Timothy C. Thompson, Chengzhen Ren
  • Patent number: 7824697
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: November 2, 2010
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Patent number: 7820439
    Abstract: The present disclosure is directed to improved methods for efficiently producing neuroprogenitor cells and differentiated neural cells such as GABAergic neurons from pluripotent stem cells, for example embryonic stem cells. Using the disclosed methods, cell populations containing a high proportion of GABAergic neurons have been isolated. The neuroprogenitor cells and terminally differentiated cells of the present disclosure can be generated in large quantities, and therefore may serve as an excellent source for cell replacement therapy in neurodegenerative disorders and neuronal diseases such as stroke, ischemia, epilepsy, and Huntington's disease.
    Type: Grant
    Filed: August 31, 2004
    Date of Patent: October 26, 2010
    Assignee: Reliance Life Sciences PVT Ltd.
    Inventors: Khan Firdos Alam, Totey Satish Mahadeorao
  • Patent number: 7818270
    Abstract: An energy tracking and reporting system can receive data inputs from multiple sources regarding one or more properties. A central database receives the information and correlates the information for numerous outputs. Information received by the central database can include, for example, property location, property size, property type and property use. Also, occupancy information, energy sources, utilities servicing the property, weather, ISO, environmental guidelines, and the traded or other standard price for the utilities can be stored. The system can calculate a number of factors from the data and return values to the central database. The system can track data trends and store additional information for budgeting, user reporting and certification compliance reporting. Modules can analyze the market rates, calculate efficiency benchmarks, analyze the data stored on the central database and provide the user with multiple tables and charts analyzing all of the factors that tie into energy usage.
    Type: Grant
    Filed: January 18, 2006
    Date of Patent: October 19, 2010
    Inventors: Margaret M. Carey, Douglas L. Pfeister, Christopher Putnam
  • Patent number: 7811817
    Abstract: Purified preparations of human embryonic stem cells with certain population-specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (?); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+), as well as a set of ES cell markers including Oct-4, Nanog, Rex1, Sox2, Thy1, FGF4, ABCG2, Dppa5, UTF1, Cripto1, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDX1 (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: October 12, 2010
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Arundhati Mandal, Shabari Tipnis, Geeta Ravindran, Jayant Kulkarni, Ameet Patki, Rajarshi Pal, Bipasha Bose, Alam Firdos Kahn, Aparna Khanna
  • Patent number: 7767756
    Abstract: The application describes materials derived from keratin proteins in combination with polymers, either as intimate mixtures with water soluble polymers, or as chemically bound copolymers. The keratin protein is a specific keratin protein fraction, and is preferably intact, s-sulfonated and from the intermediate filament protein family. The application also describes the process for production of these materials.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: August 3, 2010
    Assignee: Keraplast Technologies, Ltd.
    Inventors: Robert James Kelly, Mohammad Azam Ali, Alisa Dawn Roddick-Lanzilotta, Gillian Worth, Mohammad Mahbubul Hassan, John Robert McLaughlin, Alan John McKinnon
  • Patent number: 7753588
    Abstract: A tabless, self-opening T-shirt-styled thermoplastic bag is provided having a handle, stress relief notch, and mounting tab structure for providing a wide-opening bag mouth and a bag having high weight carrying capacity. Handles have a narrow upper portion, a wide middle portion and a narrow lower portion. Handle mounting apertures are provided in the wide middle portion, which projects inwardly above the mouth of the bag. The handle mounting apertures are formed by a blade having an elongate section that is bent to form an obtuse angle. The handle mounting aperture has a sufficient width for accommodating arms of a dispensing rack and a height about three times as great as the width. The bag has a central mounting tab extending above the mouth of the bag and between the handles. A stress relief notch having a reasonably tight radius of curvature is provided between each handle and the mounting tab.
    Type: Grant
    Filed: September 15, 2004
    Date of Patent: July 13, 2010
    Assignee: Superbag Corp.
    Inventor: Jacobo Bazbaz
  • Patent number: 7732574
    Abstract: The invention relates to a would care product that provides a biochemical environment around a wound to promote wound healing. The wound care product includes a keratin protein fraction material in which the protein fraction is intact, is from the intermediate filament protein family or the high sulfur protein family and in which the protein fraction is S-sulfonated. The invention also described a method of making a wound care product.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: June 8, 2010
    Assignee: Keraplast Technologies, Ltd.
    Inventors: Robert James Kelly, Alisa Dawn Roddick-Lanzilotta, Mohammad Azam Ali
  • Patent number: 7723475
    Abstract: The invention is directed to purified and isolated novel RGL2 polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: May 25, 2010
    Assignee: Baylor College of Medicine
    Inventors: Timothy C. Thompson, Chenghui Ren, Chengzhen Ren
  • Jug
    Patent number: D625193
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: October 12, 2010
    Assignee: HEB Grocery Company, LP
    Inventors: John C. Janney, Marvin Joseph Hetzel, Alton Warren Clark, Jr.
  • Patent number: D634613
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: March 22, 2011
    Assignee: ITI Scotland Limited
    Inventors: Stephan Massie, Seonaid Nimmo, Toby Mottram
  • Patent number: D634614
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: March 22, 2011
    Assignee: ITI Scotland Limited
    Inventors: Stephan Massie, Seonaid Nimmo, Toby Mottram
  • Patent number: D637154
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: May 3, 2011
    Assignee: Skeyedex Inc.
    Inventor: Eldrege Smith
  • Patent number: D639641
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: June 14, 2011
    Assignee: ITI Scotland Limited
    Inventors: Stephen Massie, Seonaid Nimmo, Toby Mottram